Today's Headlines
While diabetes medications Onglyza and Nesina should include information about the risk of heart failure, the drugs do not increase the risk of cardiovascular death, stroke or heart attack, an advisory committee to FDA said.
» Preliminary review details
|
A Louisiana senator is calling for a closed drug formulary for the state’s worker’s compensation program, to help combat the overutilization of opioids and compounded drugs.
» Bill details
|
Continuing Education
Last month and this month pharmacists will be able to learn about the latest developments in diabetes treatment and management. Pharmacists can earn up to 4 hours of CPE credit with two monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics. The goal of this month's activity is to discuss the recent updates of national U.S. guidelines for diabetes management, including hypertension and cholesterol management in patients with diabetes, in order to empower pharmacists in clinical decision-making.
Read/print the article: Click here
Take the test: Click here to log in with the Session Code 15DT16-TAJ88.
Announcement: Our CE activities have moved to a new learning management system to better serve you. The login to the Online CE Center is
https://web2.uconn.edu/pharmacyce/login.php. All current user registration information has been uploaded for your convenience. Current users do not need to register. To review your registration page to ensure the data is up to date or to register, go to https://web2.uconn.edu/pharmacyce/program_register.php. For a full list of courses, go to http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/
|
EDITOR'S PICK
Antibiotic-resistant methicillin-resistant Staphylococcus aureus (MRSA) exposed to cigarette smoke become even more resistant to killing by the immune system, according to a study published in Infection and Immunity. » Read more
|
|
|